| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.12 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |